Category Archives: Featured Posts

Fund Science to Fight Cancer

By | September 7, 2017

This December the United States will enter the 46th year of its longest ongoing war: the war on cancer. During this time, we have lost more lives to this disease than all U.S. military casualties since the birth of our country. The passage of the National Cancer Act in 1971 led to significant advances in… Read More »

Funding is Essential for FDA Oncology Center of Excellence

By | September 5, 2017

In early 2017, the Oncology Center of Excellence (OCE) was established by the U.S. Food and Drug Administration (FDA) to modernize the cancer drug approval process by increasing intra-agency collaboration and promoting novel regulatory ideas and processes. Among critical, medical innovation initiatives, the 21st Century Cures Act (Cures) directed the Agency to create inter-center institutes… Read More »

Basket Trials: Accelerating Precision Medicine

By | July 11, 2017

On May 23rd 2017, the cancer research community applauded a landmark accomplishment when for the first time the U.S. Food and Drug Administration (FDA) approved Merck’s pembrolizumabfor use in tumors located in any tissue. While cancers are traditionally organized and treated based on their tissue of origin, tumor sequencing has demonstrated that there are important… Read More »

Most Americans are worried about using technology to ‘Enhance’ our abilities

By | August 16, 2016

A recent study from the Pew Research Center examined how the U.S. public feels about using biomedical technology to “enhance” human abilities1. Enhancement is defined as making biochemical, surgical or other changes to improve cognitive, psychological or physical capacity. Under such a liberal definition, humanity has already been practicing self-enhancement for some time. Enhancements already… Read More »